Developing improved therapies for cytomegalovirus infections by overcoming viral strain diversity.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/2004397

Funding Status
Status not available

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Cytomegalovirus infection is the most common cause of infection-related disease in newborns and is one of the most common complications in transplant patients. Current treatments are not always successful and are associated with significant side-effects. We have therefore developed world first systems that can be used to develop safer, more effective treatments for this life-threatening infection. Our findings are likely to be applicable to other difficult to manage viral infections.

Funded Activity Details

Start Date: 01-01-2020

End Date: End date not available

Funding Scheme: Ideas Grants

Funding Amount: $1,126,820.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antibody therapy | antiviral immunity | immunotherapy | t cell immunity

Related Links